Back

Safety and efficacy of protamine administration for prevention of bleeding complications in patients with recent PCI undergoing TAVR

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Walking the line between bleeding and thrombosis in valvular heart disease Intervention ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Assistant Professor Baravan Al-Kassou

University hospital Bonn, Bonn (Germany)

6 More presentations in this session

Presentation thumbnail
Risk of thromboembolic and bleeding events in patients with atrial fibrillation after valvular intervention in either aortic or mitral position
Doctor E. Skogseid (Uppsala, SE)
Abstract Slides Video
Presentation thumbnail
Clinical outcomes in patients receiving oral anticoagulation stratified by the presence of dose reduction criteria and older age: a subanalysis of ENVISAGE-TAVI AF
Professor N. van Mieghem (Rotterdam, NL)
Abstract Slides Video
Presentation thumbnail
Anticoagulatory treatment and clinical outcomes after transcatheter aortic valve implantation: results from 45,598 patients of the German Aortic Valve Registry (GARY)
Doctor C. Hohmann (Cologne, DE)
Abstract Slides Video
Presentation thumbnail
Quality of anticoagulation and outcomes after mechanical aortic valve replacement in patients with atrial fibrillation: a nationwide cohort study
Mr J. Lehto (Turku, FI)
Abstract Slides Video
Presentation thumbnail
Efficacy of aortic valve replacement on Heyde syndrome-related acquired von Willebrand syndrome and gastrointestinal bleeding: a systematic review and meta-analysis
Mr M. Rooijakkers (Nijmegen, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Walking the line between bleeding and thrombosis in valvular heart disease

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources